Blood coagulation pathway component

Blood coagulation pathway components are a collection of plasma proteins, enzymes, and regulatory molecules that work together in a tightly controlled cascade to achieve hemostasis, resulting in the conversion of fibrinogen to fibrin and clot formation. These include the intrinsic, extrinsic, and common pathways, involving a sequential activation of factors such as factor XII, XI, IX, VIII, VII, tissue factor, X, V, II (prothrombin), I (fibrinogen), and XIII, along with important regulators like antithrombin, protein C, and protein S. Dysregulation of this system leads to bleeding disorders or pathological thrombosis, and most therapeutic interventions target specific components or regulators within these pathways for the management or prevention of thrombotic and bleeding conditions[1][2][3][5][6][7]. Note: The entry "Blood coagulation pathway components" is overly broad and refers to a system made up of numerous specific proteins (e.g., Thrombin, Factor Xa, Antithrombin). For structured biomedical databases, information should ideally be collected and entered at the level of specific factors (e.g., "Coagulation factor II, thrombin"), not for the entire class as a group, so this entry is marked is_incorrect: true for that reason[7].

Other names

coagulation factorblood clotting factorcoagulation cascade protein

Inhibition of vitamin K-dependent factor synthesis (warfarin and coumarins); Activation of antithrombin-mediated protease inhibition (heparin); Direct inhibition of thrombin (dabigatran); Direct inhibition of factor Xa (rivaroxaban, apixaban)